I'm pretty excited. I am in Amsterdam, and will be bringing you blogs straight from the biggest MS research conference in the world to date, the 5th Joint Triennial Congress of the European and Americas Committees for Treatment and Research in Multiple Sclerosis (ECTRIMS and ACTRIMS). The conference will be happening from October 19th to 22nd.
I'm looking forward to this conference on many levels. As a person living with MS, I am grateful, humbled and overwhelmed at the amount and diversity of research being done on my disease. I have to say, it can be an odd feeling to hear about data that describes the behaviors of someone with MS or some specific thing that may be happening in the body of someone with MS, knowing that that very well could be describing some of my issues or my central nervous system.
As a scientist myself, an epidemiologist, I am looking forward to "geeking out" on the research – approaching the presentations with a desire to learn what scientists are discovering, as well as how they are approaching some complex questions and challenges. I want to know why these researchers chose their topics – the people working with the mice, as well as the people looking at whole populations and their risks for MS.
Dr. Timothy Coetzee, Chief Research Officer of the National Multiple Sclerosis Society, says that this conference may lead to "new ways of thinking about MS," including possible approaches to stopping disease progression, clues as to why one person is more susceptible to MS than others, and research that could eventually show the way to repairing the damage done by MS.
In the end, what I am most interested in is what the research means for us – the people living with MS right now, as well as future generations of people who will have MS and for whom it could be prevented. I will try to answer this question and others in my blog as I try to bring the research to you in a "friendly" format, in language that is accessible and with an indication as to how this research could impact our lives.
In striving to give you an idea of the variety of research that is going to be presented at the conference, I hope that everyone will find something of interest to themselves and their specific situation. That said, I will cover topics such as:
Relapse frequency and aging
New ideas about determining if people are responding to treatment before waiting for "treatment failure"
Exposure to disease-modifying therapies during pregnancy
Patterns of treatment initiation and discontinuation
New approaches to cognitive issues
I urge you all to take a look at the research yourself. Right now, you can view abstracts for most of the presentations by going to Scientific Programme, opening up a day and browsing the topics. Later, you will be able to view the actual posters and presentations.
Tune in to this blog throughout the week to see what the latest science is revealing about MS.